BiotechTube

5 Methoxy N,N Dimethyltryptamine + Placebo

Phase 1Completed
0 watching 0 views this week💤 Quiet
28
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Healthy Volunteers

Conditions

Healthy Volunteers

Trial Timeline

Jun 21, 2021 → Nov 22, 2021

NCT ID
NCT05163691

About 5 Methoxy N,N Dimethyltryptamine + Placebo

5 Methoxy N,N Dimethyltryptamine + Placebo is a phase 1 stage product being developed by GH Research for Healthy Volunteers. The current trial status is completed. This product is registered under clinical trial identifier NCT05163691. Target conditions include Healthy Volunteers.

Hype Score Breakdown

Clinical
10
Activity
5
Company
5
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT05753956Phase 1Completed
NCT05163691Phase 1Completed

Competing Products

20 competing products in Healthy Volunteers

See all competitors
ProductCompanyStageHype Score
AZD0837AstraZenecaPhase 1
33
ValsartanNovartisPhase 1
33
CSL112 + PlaceboCSLPhase 1
32
UT-15CUnited TherapeuticsPhase 1
30
VNA-318 + PlaceboBiotrialPhase 1
25
Open-label TRV734 125 mg + TRV734 blinded + Oxycodone IR 10 mg + PlaceboTrevenaPhase 1
25
TRV130 + Moxifloxacin + PlaceboTrevenaPhase 1
25
Radiolabeled TRV130TrevenaPhase 1
25
TRV130A + Dextrose in WaterTrevenaPhase 1
25
TRV734TrevenaPhase 1
25
ALT02 + EU-licensed Herceptin + US-licensed HerceptinAlteogenPhase 1
33
ENZ215 + EU Sourced Prolia + US Sourced ProliaAlkem LaboratoriesPhase 1
33
KPL-404Kiniksa PharmaceuticalsPhase 1
28
MORF-057 + Placebo for MORF-057Eli LillyPhase 1
33
Propranolol + PseudoephedrineEli LillyPre-clinical
23
LY2157299Eli LillyPhase 1
33
Lasmiditan + PlaceboEli LillyPhase 1
33
LY3015014 + PlaceboEli LillyPhase 1
33
LOXO-783Eli LillyPhase 1
33
LY2541546 - IV + LY2541546 - SC + PlaceboEli LillyPhase 1
33

Other Products from GH Research

GH001Phase 2
47
GH001Phase 2
47
GH001 + PlaceboPhase 2
47
5 Methoxy N,N DimethyltryptaminePhase 1/2
36
5 Methoxy N,N Dimethyltryptamine + PlaceboPhase 1
28